• Channels
    • All News
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Health Tech
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Nikkei Biotechnology
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • Editorial Standards
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP

Cigna says it will not pur­sue a merg­er with Hu­mana

5 months ago
Deals
Health Tech

Dan­ish com­pa­ny pays $145M up­front to li­cense nasal spray al­ter­na­tive to EpiPen

5 months ago
Deals
Pharma

Cell ther­a­py star­tup's IPO plans thrown in lim­bo amid le­gal spat with in­vestor Al­con

5 months ago
Cell/Gene Tx
Law

Up­dat­ed: FDA ap­proves Au­to­lus’ CAR-T cell ther­a­py for ag­gres­sive blood can­cer

5 months ago
Pharma
Cell/Gene Tx

How Trump, RFK Jr. could in­flu­ence bio­phar­ma; Viking presents weight loss da­ta; Are MASH drugs get­ting boxed out by ...

6 months ago
Weekly

FDA records re­quest lands Chi­nese API man­u­fac­tur­er on blocked im­port list

6 months ago
Pharma
FDA+

GSK leaves biotech trade group BIO

6 months ago
Pharma

Am­gen and As­traZeneca share pos­i­tive re­sults in chron­ic rhi­nos­i­nusi­tis

6 months ago
R&D
Pharma

Ei­sai slash­es Leqem­bi sales fore­cast by al­most $100M

6 months ago
Pharma

Charles Riv­er to close ‘15 small­er sites’ as de­mand for ear­ly re­search de­clines

6 months ago
R&D
Outsourcing

Dai­ichi, Al­teogen to work on sub­cu­ta­neous En­her­tu; Roche ends Nykode deal

6 months ago
News Briefing

Benev­o­len­tAI’s co-founder is back. Here’s how he plans a turn­around at the AI com­pa­ny dur­ing a ‘piv­otal time’

6 months ago
AI

Leg­end names a pres­i­dent of Carvyk­ti; No­vo Nordisk's top North Amer­i­ca ex­ec is step­ping down

6 months ago
Peer Review

Nkar­ta drops an­oth­er can­cer pro­gram as it leans in­to au­toim­mune dis­ease

6 months ago
R&D

Athi­ra gives up on lead Alzheimer’s drug, switch­es tack to ALS

6 months ago
R&D

Pfiz­er to in­vest $1B in Chi­na over next five years — re­ports

6 months ago
Financing
China

Se­nior As­traZeneca ex­ec de­tained in Chi­na amid wider in­ves­ti­ga­tion

6 months ago
People
China

Stephen Squin­to's JPM life sci­ences team is rais­ing a new fund for lat­er-stage com­pa­nies

6 months ago
Financing
Startups

Soft RSV sales re­veal a vac­cine mar­ket fail­ing to catch post-Covid mo­men­tum

6 months ago
Pharma
FDA+

FDA seeks to pull OTC nasal de­con­ges­tant in­gre­di­ent due to lack of ef­fi­ca­cy

6 months ago
Pharma
FDA+

Co­herus restarts biosim­i­lar sup­ply af­ter de­lays; No­vavax ends Covid vac­cine deal with UK

6 months ago
Manufacturing

Gen­mab chops ear­ly can­cer prospects to pri­or­i­tize Phase 3 projects

6 months ago
R&D
Pharma

Au­rinia cuts near­ly half of its work­force in sec­ond round of lay­offs this year

6 months ago
R&D

Geron’s roy­al­ty deal; Minghui’s new VEGF bis­pe­cif­ic da­ta

6 months ago
News Briefing
First page Previous page 67686970717273 Next page Last page
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Health Tech
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Nikkei Biotechnology
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • Editorial Standards
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints News 2025

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
FT Specialist Logo
A service from the Financial Times
Endpoints News

Log in to your account

email

password

Endpoints News

request login link

Enter the email associated to with your Endpoints account, and we'll send you a one-time login link (no password needed). The link expires after 24 hours.

email

Endpoints News

reset password

Enter the email associated to with your Endpoints account, and we'll send you a link to reset your password. The link expires after 24 hours and can only be used once.

email

Endpoints News

Sign up for free to read a limited number of articles each month.

About You

Newsletter Interests

Pick what newsletters get delivered to your inbox each week.

Biopharma

ENDPOINTS NEWS Daily at 11:30 AM ET

EARLY EDITION Daily at 7:15 AM ET

ENDPOINTS PHARMA Daily at 3:30 PM ET

BREAKING NEWS ALERTS 2-3 times a week

ENDPOINTS FDA+ Wed at 2 PM ET

ENDPOINTS MANUFACTURING Thu at 2 PM ET

ENDPOINTS WEEKLY Sat at 6 AM ET

POST-HOC 1-2 times a week

Healthcare

ENDPOINTS HEALTH TECH Tuesday, Thursday at 10 AM ET

BREAKING NEWS ALERTS 2-3 times a week

Want unlimited access? Sign up for a premium subscription plan.